WIRE: Clinical Trial of CBD reduces anxiety in healthy volunteers
Ribeirao, Brazil: The administration of cannabidiol reduces anxiety in healthy subjects, according to placebo-controlled clinical trial data published in The Brazilian [...]
clinical trial
WIRE: Study shows oral THC safe and effective treatment for symptoms of anorexia
Jerusalem, Israel: The daily administration of low doses of oral THC is associated with treating various symptoms associated with anorexia nervosa, according to clinical [...]
WIRE: Study indicates CBD is effective as adjunctive therapy for psychosis
London, United Kingdom — The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, [...]
WIRE: Israeli study finds gelatin CBD capsules are safe and effective
Tel Aviv, Israel — The oral administration of gelatin capsules containing purified cannabidiol (CBD) is safe and efficient in human subjects, according to clinical [...]
WIRE: Literature survey shows cannabis effective for pain, epilepsy and MS
Boston, MA: Substantial clinical trial data exists to support the efficacy of medical cannabis in the treatment of chronic pain conditions, pediatric epilepsy, and multiple [...]
WIRE: Oral THC mitigates sleep apnea in new study
Chicago, IL — The use of oral THC mitigates sleep apnea symptoms compared to placebo, according to clinical trial data published online ahead of print in the [...]
WIRE: CBD administration reduces blood pressure in new study
Oxford, United Kingdom — Oral CBD administration is associated with reduced blood pressure in healthy volunteers, according to clinical trial data published online in [...]
WIRE: Study shows cannabis extract associated with reduced ADHD symptoms
London, United Kingdom — The administration of whole-plant cannabis extracts is associated with improvements in cognition and behavior in subjects with Attention [...]
WIRE: Canadian company prepares phase III trial for smoked cannabis cancer pain treatment
OTTAWA, ONTARIO – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP)(OTCQB: TBPMF), and PhytoPain Pharma (PPP), a subsidiary of Tetra [...]
WIRE: In new study, CBD reduces seizures in severe epilepsy disorder
NEW YORK — After years of anecdotal claims about its benefits, the cannabis derivative cannabidiol reduced seizure frequency by 39 percent for patients with Dravet [...]